Jolanda Howe - 16 Oct 2026 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
19 Oct 2026, 16:10:05 UTC
Prior SEC filing
03 Sep 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Judit Ryvkin, Attorney-in-Fact
Filing notes and source

Key filing fact

Jolanda Howe filed Form 4 for Mirum Pharmaceuticals, Inc. (MIRM) on 19 Oct 2026.

Key facts

  • This page summarizes Jolanda Howe's Form 4 filing for Mirum Pharmaceuticals, Inc. (MIRM).
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 19 Oct 2026, 16:10.

Change

  • Previous filing in this sequence was filed on 03 Sep 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001974200 Primary reporting owner

Howe Jolanda

Relationship
SVP, GLOBAL CONTROLLER
Address
C/O MIRUM PHARMACEUTICALS, INC., 989 E HILLSDALE BLVD., SUITE 300, FOSTER CITY
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
Signature date
19 Oct 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MIRM transaction

Common Stock

Options Exercise

Transaction value
Shares
+16,112
Change %
+2616%
Price
$19.24*
Shares after
16,728
Date
16 Oct 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MIRM transaction Derivative

Employee Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-16,112
Change %
-64%
Price
$0.000000*
Shares after
8,888
Date
16 Oct 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
16,112
Exercise price
$19.24
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The stock option is fully vested.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .